OBJECTIVES: There are currently no diagnostic indicators that are consistently reliable, obtainable, and conclusive for diagnosing and risk-stratifying pancreatic cysts. Proteomic analyses were performed to explore pancreatic cyst fluids to yield effective diagnostic biomarkers. METHODS: We have prospectively recruited 20 research participants and prepared their pancreatic cyst fluids specifically for proteomic analyses. Proteomic approaches applied were as follows: (1) matrix-assisted laser-desorption-ionization time-of-flight mass spectrometry peptidomics with LC/MS/MS (HPLC-tandem mass spectrometry) protein identification; (2) 2-dimensional gel electrophoresis; (3) GeLC/MS/MS (tryptic digestion of proteins fractionated by sodium dodecyl sulfate-polyacrylamide gel electrophoresis and identified by LC/MS/MS). RESULTS: Sequencing of more than 350 free peptides showed that exopeptidase activities rendered peptidomics of cyst fluids unreliable; protein nicking by proteases in the cyst fluids produced hundreds of protein spots from the major proteins, making 2-dimensional gel proteomics unmanageable; GeLC/MS/MS revealed a panel of potential biomarker proteins that correlated with carcinoembryonic antigen (CEA). CONCLUSIONS: Two homologs of amylase, solubilized molecules of 4 mucins, 4 solubilized CEA-related cell adhesion molecules (CEACAMs), and 4 S100 homologs may be candidate biomarkers to facilitate future pancreatic cyst diagnosis and risk-stratification. This approach required less than 40 microL of cyst fluid per sample, offering the possibility to analyze cysts smaller than 1 cm in diameter.
OBJECTIVES: There are currently no diagnostic indicators that are consistently reliable, obtainable, and conclusive for diagnosing and risk-stratifying pancreatic cysts. Proteomic analyses were performed to explore pancreatic cyst fluids to yield effective diagnostic biomarkers. METHODS: We have prospectively recruited 20 research participants and prepared their pancreatic cyst fluids specifically for proteomic analyses. Proteomic approaches applied were as follows: (1) matrix-assisted laser-desorption-ionization time-of-flight mass spectrometry peptidomics with LC/MS/MS (HPLC-tandem mass spectrometry) protein identification; (2) 2-dimensional gel electrophoresis; (3) GeLC/MS/MS (tryptic digestion of proteins fractionated by sodium dodecyl sulfate-polyacrylamide gel electrophoresis and identified by LC/MS/MS). RESULTS: Sequencing of more than 350 free peptides showed that exopeptidase activities rendered peptidomics of cyst fluids unreliable; protein nicking by proteases in the cyst fluids produced hundreds of protein spots from the major proteins, making 2-dimensional gel proteomics unmanageable; GeLC/MS/MS revealed a panel of potential biomarker proteins that correlated with carcinoembryonic antigen (CEA). CONCLUSIONS: Two homologs of amylase, solubilized molecules of 4 mucins, 4 solubilized CEA-related cell adhesion molecules (CEACAMs), and 4 S100 homologs may be candidate biomarkers to facilitate future pancreatic cyst diagnosis and risk-stratification. This approach required less than 40 microL of cyst fluid per sample, offering the possibility to analyze cysts smaller than 1 cm in diameter.
Authors: N Beauchemin; P Draber; G Dveksler; P Gold; S Gray-Owen; F Grunert; S Hammarström; K V Holmes; A Karlsson; M Kuroki; S H Lin; L Lucka; S M Najjar; M Neumaier; B Obrink; J E Shively; K M Skubitz; C P Stanners; P Thomas; J A Thompson; M Virji; S von Kleist; C Wagener; S Watt; W Zimmermann Journal: Exp Cell Res Date: 1999-11-01 Impact factor: 3.905
Authors: Theresa Pluth Yeo; Ralph H Hruban; Steven D Leach; Robb E Wilentz; Taylor A Sohn; Scott E Kern; Christine A Iacobuzio-Donahue; Anirban Maitra; Michael Goggins; Marcia I Canto; Ross A Abrams; Daniel Laheru; Elizabeth M Jaffee; Manuel Hidalgo; Charles J Yeo Journal: Curr Probl Cancer Date: 2002 Jul-Aug Impact factor: 3.187
Authors: Xin-Ming Li; Bhavinkumar B Patel; Elena L Blagoi; Maketa D Patterson; Steven H Seeholzer; Steven H Seehozer; Tao Zhang; Shirish Damle; Zhenqiang Gao; Bruce Boman; Anthony T Yeung Journal: J Proteome Res Date: 2004 Jul-Aug Impact factor: 4.466
Authors: R E Wilentz; J Albores-Saavedra; M Zahurak; M A Talamini; C J Yeo; J L Cameron; R H Hruban Journal: Am J Surg Pathol Date: 1999-11 Impact factor: 6.394
Authors: William R Brugge; Kent Lewandrowski; Elizabeth Lee-Lewandrowski; Barbara A Centeno; Tara Szydlo; Susan Regan; Carlos Fernandez del Castillo; Andrew L Warshaw Journal: Gastroenterology Date: 2004-05 Impact factor: 22.682
Authors: Ali R Shekouh; Christopher C Thompson; Wendy Prime; Fiona Campbell; Jane Hamlett; C Simon Herrington; Nicholas R Lemoine; Tatjana Crnogorac-Jurcevic; Markus W Buechler; Helmut Friess; John P Neoptolemos; Stephen R Pennington; Eithne Costello Journal: Proteomics Date: 2003-10 Impact factor: 3.984
Authors: Diego Preciado; Samita Goyal; Michael Rahimi; Alan M Watson; Kristy J Brown; Yetrib Hathout; Mary C Rose Journal: Pediatr Res Date: 2010-09 Impact factor: 3.756
Authors: Salim Merali; Carlos A Barrero; Russell P Bowler; Diane Er Chen; Gerard Criner; Alan Braverman; Samuel Litwin; Anthony Yeung; Steven G Kelsen Journal: COPD Date: 2013-10-10 Impact factor: 2.409
Authors: Katie Partyka; Mitchell McDonald; Kevin A Maupin; Randall Brand; Richard Kwon; Diane M Simeone; Peter Allen; Brian B Haab Journal: J Proteome Res Date: 2012-04-04 Impact factor: 4.466
Authors: Kathryn T Chen; Phillip D Kim; Kelly A Jones; Karthik Devarajan; Bhavinkumar B Patel; John P Hoffman; Hormoz Ehya; Min Huang; James C Watson; Jeffrey L Tokar; Anthony T Yeung Journal: Pancreas Date: 2014-01 Impact factor: 3.327
Authors: Joao A Paulo; Vivek Kadiyala; Aleksandr Gaun; John F K Sauld; Ali Ghoulidi; Peter A Banks; Hanno Steen; Darwin L Conwell Journal: JOP Date: 2013-03-10